AIDS

How Web Conferencing Is Helping HIV/AIDS Patients in Kenya

Blog

This post was written by Dr. Stanley Ndwiga, Outreach/Project Doctor at Gertrude’s Children’s Hospital in Nairobi, Kenya. It was originally published on the Huffington Post.

World AIDS Day

Blog

The guest blog comes from Lilly's Vice President of Global Health Programs and Access, Dr. Evan Lee.

We Have the Power to End AIDS, TB and Malaria

Blog

Today's guest blog comes from Lilly's Vice President of Global Health Programs and Access, Dr. Evan Lee.

From Vision to Reality: Haiti’s Largest Public Sector Hospital Opens with Support from the GE Foundation: A Q&A with Hector E. Aguilar

Blog

The 2010 earthquake in Haiti was the second deadliest earthquake of all time. With a magnitude of 7.0 Mw, 220,000 people were killed, and more than 250,000 homes were destroyed. In the earthquake’s aftermath, many Haitians desperately needed medical care. In December 2010, the GE Foundation made a $2 million commitment to help build a new public hospital that would be Haiti’s largest post-earthquake public health facility. Hector E. Aguilar, CEO of GE Central America & The Caribbean, discusses the GE Foundation’s role and the opening of the hospital.

Janssen Announces Intent Not to Enforce Patents for Darunavir in Resource-Limited Settings

Policy Aims to Support a Sustainable Supply of Medically Acceptable Generic Darunavir in Sub-Saharan Africa (SSA) and Least Developed Countries (LDC)
Press Release

November 29, 2012 /3BL Media/ - The Janssen Pharmaceutical Companies of Johnson & Johnson today announced their intention not to enforce the patents they own and control on the antiretroviral (ARV) drug darunavir provided the darunavir product is medically acceptable and is used only in resource-limited settings.[1] This announcement is intended to assure generic manufacturers that they may manufacture high quality darunavir product used in SSA and the LDCs without a concern that Janssen will accuse these activities of infringing its darunavir patents.

World AIDS Day: Kenneth Cole Joins Group of CEOs to Call to End HIV Travel Restrictions

Global Leaders Oppose Policies as Discriminatory and Bad for Business
Press Release

NEW YORK, Nov. 28, 2012 /3BL Media/ - This World AIDS Day, Chief Executives from some of the world’s largest companies are calling for an end to travel restrictions for people living with HIV.

More than 40 CEOs have signed an unprecedented pledge urging the repeal of laws and policies in 45 countries that still deport, detain or deny entry to people solely because they are living with HIV.

Eliminating Pediatric AIDS

We’re working with partners to end new HIV infections in children by 2015 and keep their mothers alive.
Article

Approximately 900 children are newly infected with HIV every day, and nearly all of these children acquire HIV from their mothers during pregnancy, childbirth or breastfeeding.  However, effective, inexpensive and safe medical interventions that prevent HIV transmission to infants and protect the health of their mothers are available, even in settings where resources are constrained.

Kenneth Cole Joins Companies Fighting to Lift Travel Restrictions for People Living with HIV

CEOs from the world’s leading companies call on 46 countries to repeal HIV-related travel restrictions
Press Release

(3BL Media) Washington - July 23, 2012 - Prominent CEOs from the world’s leading companies, including Levi Strauss & Co., The Coca-Cola Company, Johnson & Johnson, the National Basketball Association (NBA) and Virgin Unite, called today on 46 countries to lift travel restrictions for HIV-positive people. 

More than 20 CEOs from leading companies have signed a pledge to oppose HIV-related restrictions on entry, stay and residence, saying such laws and policies are not only discriminatory, they are bad for business. 

Pages

Subscribe to AIDS